The inherited nature of lung cancer: a pilot study

被引:33
|
作者
Wood, ME
Kelly, K
Mullineaux, LG
Bunn, PA
机构
[1] Univ Vermont, FAHC, Div Hematol & Oncol, Burlington, VT 05401 USA
[2] Univ Colorado, Sch Med, Div Med Oncol, Denver, CO 80262 USA
关键词
lung cancer; genetics; family history; cancer genetics; inherited cancer; genetic predisposition;
D O I
10.1016/S0169-5002(00)00142-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of both primary and secondary cigarette smoke exposure in the causation of lung cancer appears certain. An estimated 90% of lung cancer is attributed to cigarette smoke. Remarkably, however, less then 20% of cigarette smokers develop lung cancel. Investigators have suggested that a genetic predisposition to lung cancer may contribute to familial aggregation of this cancer. To understand the contribution of familial aggregation to this type of cancer and potentially identify individuals and families, which may be important in identifying gene(s) responsible for lung cancer, we developed criteria for identification of high-risk families. We have tested the feasibility and utility of, these criteria at three Denver, CO hospitals with very different patient populations. Four hundred eighteen individuals were diagnosed with lung cancel at these three hospitals between 1/1/95 and 8/31/95. Twenty-nine percent of individuals expired prior to the time of initial contact. Family history data were obtained on 182 individuals. To be considered positive (suggesting possible autosomal dominant inheritance of lung cancer), families must have at least two first-degree relatives with lung cancer, one of which must be diagnosed before the age of 55. Seventeen of 182 (9.3%) families in the study population met these criteria. We reviewed the remaining family histories that did not meet the established criteria and identified another 2.3% (5/182) of families had evidence for autosomal dominant transmission of lung cancer. An additional 15% (23/182) of families had histories which could not be classified without further information. This study suggests that at least 11.6% of individuals diagnosed with lung cancer will have a positive family history of lung cancer. Use of the criteria developed for this study may lead to an underestimation of the inherited etiology of lung cancer. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 50 条
  • [1] THE NATURE OF INHERITED SUSCEPTIBILITY TO CANCER
    HARNDEN, DG
    CARCINOGENESIS, 1984, 5 (12) : 1535 - 1537
  • [2] Inherited lung cancer: a review
    Loiola de Alencar, Viviane Teixeira
    Formiga, Maria Nirvana
    Cordeiro de Lima, Vladmir Claudio
    ECANCERMEDICALSCIENCE, 2020, 14
  • [3] Lung cancer referral patterns - A pilot study
    Crawford, SM
    Melling, P
    BRITISH JOURNAL OF CANCER, 1998, 78 : 41 - 41
  • [4] INHERITED PREDISPOSITION TO LUNG-CANCER
    HASDAY, JD
    MCCREA, KA
    OCCUPATIONAL MEDICINE-STATE OF THE ART REVIEWS, 1992, 7 (02): : 227 - 240
  • [5] Lung Cancer Survivorship Programme CUH: Pilot Study
    Guiry, S.
    Grant, C.
    O'Grady, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S533 - S533
  • [6] Modafinil for the treatment of fatigue in lung cancer: a pilot study
    Spathis, A.
    Dhillan, R.
    Booden, D.
    Forbes, K.
    Vrotsou, K.
    Fife, K.
    LUNG CANCER, 2008, 60 : S4 - S4
  • [7] HORMONAL RECEPTOR EXPRESSION IN LUNG CANCER: A PILOT STUDY
    Longo, M.
    Monica, V
    Capelletto, E.
    Pandiscia, S.
    Crida, B.
    Levra, Giaj M.
    Rapetti, S. G.
    Novello, S.
    ANNALS OF ONCOLOGY, 2009, 20
  • [8] ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY
    Esposito, F.
    Palumbo, F.
    Romano, C.
    Giorgione, C.
    Mormone, A.
    Nevola, R.
    Galiero, R.
    Caturano, A.
    Vetrano, E.
    Sasso, F. C.
    Rinaldi, L.
    WORLD CANCER RESEARCH JOURNAL, 2023, 10
  • [9] Assessing coughing and wheezing in lung cancer: A pilot study
    Chernecky, C
    Sarna, L
    Waller, JL
    Brecht, ML
    ONCOLOGY NURSING FORUM, 2004, 31 (06) : 1095 - 1101
  • [10] Modafinil for the treatment of fatigue in lung cancer: a pilot study
    Spathis, A.
    Dhillan, R.
    Booden, D.
    Forbes, K.
    Vrotsou, K.
    Fife, K.
    PALLIATIVE MEDICINE, 2009, 23 (04) : 325 - 331